Cas 262275-08-1,4-FLUORO-N-(1-HYDRAZINO-2-NITROVINYL)ANILINE

262275-08-1

Post Buying Request

Basic information

Product Name: 4-FLUORO-N-(1-HYDRAZINO-2-NITROVINYL)ANILINE
Synonyms: N-(4-FLUOROPHENYL)-N-(1-HYDRAZINO-2-NITROVINYL)AMINE;4-FLUORO-N-(1-HYDRAZINO-2-NITROVINYL)ANILINE;4-fluoro-N-[(Z)-1-hydrazinyl-2-nitroethenyl]aniline
CAS NO:262275-08-1
Molecular Formula: C8H9FN4O2
Molecular Weight: 212.18
EINECS: N/A
Product Categories: N/A
Mol File: 262275-08-1.mol

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: /
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-FLUORO-N-(1-HYDRAZINO-2-NITROVINYL)ANILINE(CAS DataBase Reference)
NIST Chemistry Reference: 4-FLUORO-N-(1-HYDRAZINO-2-NITROVINYL)ANILINE(262275-08-1)
EPA Substance Registry System: 4-FLUORO-N-(1-HYDRAZINO-2-NITROVINYL)ANILINE(262275-08-1)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 262275-08-1(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

262275-08-1 Suppliers

Recommended suppliers

262275-08-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 262275-08-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,2,2,7 and 5 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 262275-08:
(8*2)+(7*6)+(6*2)+(5*2)+(4*7)+(3*5)+(2*0)+(1*8)=131
131 % 10 = 1
So 262275-08-1 is a valid CAS Registry Number.

262275-08-1Upstream product

262275-08-1Downstream Products

262275-08-1Relevant academic research and scientific papers

HETEROARYLMETHYLENE DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS

-

, (2020/08/22)

Disclosed herein are certain acetamido derivatives that are DNA Polymerase Theta (Polθ) inhibitors of Formula (I). Also, disclosed are pharmaceutical compositions comprising such compounds and methods of treating diseases treatable by inhibition of Polθ such as cancer, including homologous recombination (HR) deficient cancers.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 262275-08-1